GlassScriptPhysician profile
Tommy L Hicks
NPI 1760513758
$1,883.78
in general payments reported to CMS, 2019-2025
31 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $344 · 2020: $322 · 2021: $455 · 2022: $308 · 2023: $239 · 2024: $216.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $455.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $455.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $242.44 | 2019-2024 | Evenity, Prolia |
| Bayer Healthcare Pharmaceuticals INC. | $152.30 | 2021-2023 | |
| Novartis Pharmaceuticals Corporation | $131.33 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $122.40 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $118.40 | 2019-2024 | Xifaxan |
| Abbvie INC. | $110.68 | 2021-2023 | |
| Astellas Pharma US INC | $108.28 | 2019-2021 | |
| Inari Medical, INC. | $88.34 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Amarin Pharma, INC. | $74.19 | 2020 | |
| Pfizer INC. | $72.65 | 2019-2024 | |
| Lundbeck LLC | $65.30 | 2023-2024 | Rexulti |
| Otsuka America Pharmaceutical, INC. | $64.85 | 2023 | Rexulti |
| Eisai INC. | $62.48 | 2020-2022 | |
| Boston Scientific Corporation | $53.46 | 2019-2022 | |
| Allergan, INC. | $52.59 | 2019-2020 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $47.73 | 2020-2021 | |
| Novo Nordisk INC | $40.35 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $28.85 | 2021-2022 | |
| Avanir Pharmaceuticals, INC. | $27.20 | 2022 | |
| Alexion Pharmaceuticals, INC. | $25.50 | 2021 | |
| Sun Pharmaceutical Industries INC. | $24.08 | 2021 | |
| Radius Health, INC. | $23.82 | 2020 | |
| Lilly USA, LLC | $19.95 | 2024 | Amyvid |
| Genentech USA, INC. | $19.43 | 2021 | |
| Exact Sciences Corporation | $18.63 | 2024 | Cologuard Collection Kit |
| Biogen, INC. | $18.36 | 2021 | |
| Tactile Systems Technology INC | $16.47 | 2021 | |
| Sanofi Pasteur INC. | $15.64 | 2020 | |
| Nestle Healthcare Nutrition INC. | $13.57 | 2022 | |
| Seqirus USA INC | $13.01 | 2019 | |
| Endogastric Solutions, INC | $11.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tommy Hicks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.